Multifunctional graphene oxide nanoparticles for drug delivery in cancer

AM Itoo, SL Vemula, MT Gupta, MV Giram… - Journal of Controlled …, 2022 - Elsevier
Recent advancements in nanotechnology have enabled us to develop sophisticated
multifunctional nanoparticles or nanosystems for targeted diagnosis and treatment of several …

Hyaluronic acid: redefining its role

G Abatangelo, V Vindigni, G Avruscio, L Pandis, P Brun - Cells, 2020 - mdpi.com
The discovery of several unexpected complex biological roles of hyaluronic acid (HA) has
promoted new research impetus for biologists and, the clinical interest in several fields of …

Hyaluronic acid in the third millennium

A Fallacara, E Baldini, S Manfredini, S Vertuani - Polymers, 2018 - mdpi.com
Since its first isolation in 1934, hyaluronic acid (HA) has been studied across a variety of
research areas. This unbranched glycosaminoglycan consisting of repeating disaccharide …

Formulation of poloxamers for drug delivery

AM Bodratti, P Alexandridis - Journal of functional biomaterials, 2018 - mdpi.com
Poloxamers, also known as Pluronics®, are block copolymers of poly (ethylene oxide)(PEO)
and poly (propylene oxide)(PPO), which have an amphiphilic character and useful …

Halfway between 2D and animal models: are 3D cultures the ideal tool to study cancer-microenvironment interactions?

J Hoarau-Véchot, A Rafii, C Touboul… - International journal of …, 2018 - mdpi.com
An area that has come to be of tremendous interest in tumor research in the last decade is
the role of the microenvironment in the biology of neoplastic diseases. The tumor …

Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy

E Pérez-Herrero, A Fernández-Medarde - European journal of …, 2015 - Elsevier
Cancer is the second worldwide cause of death, exceeded only by cardiovascular diseases.
It is characterized by uncontrolled cell proliferation and an absence of cell death that, except …

Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer

S Misra, VC Hascall, RR Markwald… - Frontiers in …, 2015 - frontiersin.org
The glycosaminoglycan hyaluronan (HA), a major component of extracellular matrices, and
cell surface receptors of HA have been proposed to have pivotal roles in cell proliferation …

Hyaluronic acid for anticancer drug and nucleic acid delivery

F Dosio, S Arpicco, B Stella, E Fattal - Advanced drug delivery reviews, 2016 - Elsevier
Hyaluronic acid (HA) is widely used in anticancer drug delivery, since it is biocompatible,
biodegradable, non-toxic, and non-immunogenic; moreover, HA receptors are …

Application of hyaluronic acid as carriers in drug delivery

G Huang, H Huang - Drug delivery, 2018 - Taylor & Francis
Hyaluronic acid has good biocompatibility, biodegradability, and nonimmunogenicity. In
addition, it has the ability to recognize specific receptors that are overexpressed on the …

Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system

G Huang, H Huang - Journal of Controlled Release, 2018 - Elsevier
Hyaluronic acid (HA) is a natural polysaccharide with good biocompatibility and
degradability. HA and its derivatives can be used as sustained-release carriers for drugs …